Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.

ABSTRACT:

Background

The value of frequent, rapid testing to reduce community transmission of SARS-CoV-2 is poorly understood.

Objective

To define performance standards and predict the clinical, epidemiologic, and economic outcomes of nationwide, home-based antigen testing.

Design

A simple compartmental epidemic model that estimated viral transmission, portrayed disease progression, and forecast resource use, with and without testing.

Data sources

Parameter values and ranges as informed by Centers for Disease Control and Prevention guidance and published literature.

Target population

U.S. population.

Time horizon

60 days.

Perspective

Societal; costs included testing, inpatient care, and lost workdays.

Intervention

Home-based SARS-CoV-2 antigen

SUBMITTER: Paltiel AD 

PROVIDER: S-EPMC9317280 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature